Non-oral long-acting drug delivery systems (LADDS) encompass a range of technologies for
precisely delivering drug molecules into target tissues either through the systemic circulation …

Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis and
manifests as a complex and dysregulated immune response. To date, there is no cure for …

A major drawback of oral treatment of inflammatory bowel disease (IBD) is the non-specific
distribution of drugs during long-term treatment. Despite its effectiveness as an anti …

Spores, the dormant life forms of probiotics, can germinate to metabolically active vegetative
cells with the disintegration of their hydrophobic protein coat in the intestinal …

Current treatments for intestinal diseases including inflammatory bowel diseases, irritable
bowel syndrome, and colonic bacterial infections are typically small molecule oral dosage …

Anti-inflammatory drugs for ulcerative colitis (UC) treatment should specifically penetrate
and accumulate in the colon tissue. Herein, a multi-bioresponsive anti-inflammatory drug …

In the present experimental series, we have developed a novel nanocomposite to target
activated macrophages in the colon with real time imaging and therapeutic capabilities. This …

Iron‐based magnetic nanoparticles (MNPs) have been studied extensively for the past few
decades. They have been applied in various applications, particularly in the biomedical …

The primary focus of this review is a discussion regarding in vitro media for colon release,
but we also give a brief overview of colon delivery and the colon microbiota as a baseline for …

Abstract Inflammatory Bowel Diseases (IBD) is a debilitating condition that affects~ 70,000
new people every year and has been described as “an expensive disease with no known …